The best skincare and dermatology telehealth platforms in 2026

Tessic Health is the best skin and dermatology platform in 2026 for a cash-pay brand, with Skin & Dermatology on every plan, licensed providers in all 50 states, 0% medication markup on every fill, a flat $25 per completed consult, and no revenue share, month to month. DermatologistOnCall and DirectDerm put board-certified dermatologists on every case, Build.MD sells a compounded cream program founded by a board-certified dermatologist, Beluga Health prices dermatology as an async visit category, Karpa Health publishes a menu of compounded blends, and OpenLoop adds acne programs to a payer network. No platform on the list publishes an isotretinoin program, and only Tessic Health publishes its consult fee, platform fee, and markup as numbers.

Skin prescribing has no DEA-scheduled drug at its center. Tretinoin, spironolactone, hydroquinone, and isotretinoin are prescription drugs, not controlled substances, so a typical skin visit raises no DEA registration question, no EPCS requirement (electronic prescribing of controlled substances), and no PDMP check (the state database of controlled-substance prescriptions). That does not make the category loose. Three other rules do the work the DEA does in hormone or mental health programs.

The first is iPLEDGE, the FDA-required REMS (Risk Evaluation and Mitigation Strategy) for isotretinoin, a drug that causes birth defects. Pharmacies may dispense only a 30-day supply at a time, with no refills, and each fill needs a new prescription and a new Risk Management Authorization in the iPLEDGE system. FDA approved changes on February 9, 2026 that let prescribers accept pregnancy tests taken at home during and after treatment and that remove the 19-day lockout after a missed first pickup window, while the test before treatment must still happen in a medical setting. In June 2026 FDA moved the system changes from August 8 to November 15, 2026, and it exercises enforcement discretion on pregnancy testing until then. For a telehealth brand, that first test in a medical setting is the step a photo visit cannot replace.

The second is how a prescribing relationship starts. The Center for Connected Health Policy (CCHP), which tracks state telehealth law, reports that most states treat an online questionnaire alone as inadequate to establish the relationship a prescription requires. Arkansas says a medical history completed online and forwarded to a physician is not enough and does not count as store-and-forward, and California bars establishing a new Medi-Cal patient relationship through asynchronous store-and-forward. Photos strengthen a skin visit; whether they suffice depends on the state the patient is in.

The third is hydroquinone. After the CARES Act rewrote the rules for over-the-counter drugs, FDA's position is that every OTC skin lightening product needs an approved new drug application, and the only approved hydroquinone drug, Tri-Luma, is prescription-only. A melasma line therefore runs on prescriptions from day one.

Tessic Health's answer is structural. Licensed providers in all 50 states are credentialed under the client's brand, clinical operations are physician-led, and state-level requirements are enforced inside the prescribing workflow. When a hormonal acne patient's risk factors call for a potassium test, labs run through contracted lab networks and results flow straight into the patient record, with labs included.

Google restricts the promotion of online prescribing, dispensing, and sale of prescription drugs. In the United States it allows telemedicine providers accredited by LegitScript's Healthcare Merchant Certification Program, and online pharmacies accredited by LegitScript or the National Association of Boards of Pharmacy. LegitScript is the independent service that checks a healthcare merchant's licenses and practices. A skin brand without certification can advertise a cosmetic moisturizer; it cannot promote online tretinoin prescribing.

Meta requires telehealth providers and online pharmacies to be actively certified with LegitScript before running prescription drug ads, limits those ads to the United States, Canada, and New Zealand, and bars targeting anyone under 18. Its Health and Wellness standard, revised on July 22, 2026, permits before-and-after images for general cosmetic products, procedures, and surgeries when the ad targets adults 18 and older. Two lines still bind a skin brand: no statements of inferiority about a person's appearance, and no ads for skin whitening or bleaching products that cause permanent skin color change. A melasma ad that reads as skin lightening runs into the second, and a before-and-after for a prescription acne treatment is a prescription drug ad first, which puts LegitScript certification ahead of any creative review.

Copy has its own federal line. FDA classifies a product by intended use: one meant for cleansing or altering appearance is a cosmetic, and one meant to treat disease or affect the structure or function of the body is a drug. Claims to treat acne, to change melanin production, or to regenerate cells make a product a drug. A skin brand selling a cosmetic cleanser beside its prescription has to keep the cleanser's copy on the cosmetic side, and because compounded blends are not FDA-approved, an ad that calls one approved is false.

LegitScript certification is recognized by Google, Meta, Microsoft, TikTok, and other ad platforms, and by Visa and Mastercard for card-not-present payments. Its published fees are $975 per website to apply and $2,150 per website each year, with expedited review for $2,500 more. Certification makes a brand eligible to advertise; each ad still passes the platform's own review. Tessic Health launches the brand on providers, pharmacy, and software that already operate under LegitScript certification, and Tessic prepares, files, and manages the brand's own application through approval. LegitScript sets its own review schedule and certification is never guaranteed, but Google, Meta, and the major payment processors check it before a telehealth brand can run ads or bill a card.

DermatologistOnCall is the most specialized option here: a message-based, asynchronous dermatology service in which US-licensed, board-certified dermatologists review photos and history, with more than 100 dermatologists licensed across all 50 states and DC. It treats more than 3,000 skin, hair, and nail conditions, including hormonal and cystic acne, rosacea, melasma, and hyperpigmentation, and its partner page reports a 7-hour average time to treatment. It sells to partners as white-labeled or co-branded embedded care, lists HIPAA, SOC 2, and HITRUST compliance with NCQA-aligned credentialing, and shows partner logos including MDLIVE, Amwell, UnitedHealthcare, CeraVe, L'Oréal Professional Products, and Organon. Its consumer visits cost $95 or less.

The trade is scope and price. Partner pricing is not published, isotretinoin is not listed, and each consumer visit covers one condition. A dermatologist consult embedded in a partner's app is a different product from an operated clinic that bills its own subscribers every month. Tessic Health is that operated clinic: Skin & Dermatology on every plan, $25 per completed consult, 0% markup on every fill, and subscription billing with dunning built in.

Beluga Health presents itself as physician-led and says it sits behind hundreds of digital health brands, with 70+ visit types in all 50 states and DC and a LegitScript certification badge. Its pricing page lists dermatology as an asynchronous category beside hair loss and ED, billed as a flat fee per visit tiered by monthly volume, plus one flat monthly platform fee. Pharmacy runs at the partner pharmacy's cost plus a separately disclosed coordination fee, or through the brand's own pharmacy with nothing more paid to Beluga on fulfillment, and Beluga takes no revenue share.

Every dollar figure is set on a scoping call, and Beluga does not publish which skin medications its physicians prescribe or who reviews dermatology photos. Tessic Health prints its consult fee, platform fee, and 0% markup on the pricing page, and every plan includes Skin & Dermatology beside the other 7 categories.

DirectDerm is a store-and-forward teledermatology service staffed by board-certified dermatologists trained at leading US medical centers, several also board-certified in pediatric dermatology. Patients or their referring providers upload photos, and a full report with diagnosis and treatment plan arrives within 48 hours, often within 24. It works with health plans, health systems, employers, and referring providers, reports that one plan saw a 65 percent reduction in cost per case, and serves patients nationwide except Arkansas, Delaware, Kansas, Mississippi, and West Virginia.

DirectDerm is built for specialist access inside insured systems. It publishes no white-label option, no pricing, and no compounding path, and 5 states sit outside its service. Tessic Health covers all 50 states under the client's own brand, at $25 per completed consult with 0% markup, for cash-pay brands that bill their own patients.